Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 57883-25-7 | MDL No. : | MFCD00234309 |
Formula : | C7H8BrNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KLQBFCAXXZMOLZ-UHFFFAOYSA-N |
M.W : | 202.05 | Pubchem ID : | 10987308 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 43.24 |
TPSA : | 22.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.96 cm/s |
Log Po/w (iLOGP) : | 2.35 |
Log Po/w (XLOGP3) : | 2.21 |
Log Po/w (WLOGP) : | 2.24 |
Log Po/w (MLOGP) : | 1.65 |
Log Po/w (SILICOS-IT) : | 2.33 |
Consensus Log Po/w : | 2.16 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.8 |
Solubility : | 0.322 mg/ml ; 0.0016 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.31 |
Solubility : | 0.992 mg/ml ; 0.00491 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.42 |
Solubility : | 0.0777 mg/ml ; 0.000385 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.76 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H227-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | With sodium hydride In tetrahydrofuran; mineral oil at 20℃; for 3 h; Inert atmosphere | A 60percent dispersion of sodium hydride in mineral oil (7.4 g, 184.6 mmol) was suspended in anhydrous tetrahydrofuran (300 mL) under nitrogen. Absolute ethanol (10.0 mL, 170.4 mmol) was added dropwise at room temperature and the reaction mixture was stirred for 40 minutes at room temperature. 2-Fluoro-3-bromopyridine (25.0 g, 142.0 mmol) was added and the reaction mixture was stirred for 3 hours at room temperature. Water (250 mL) was added and the organic layer was separated. The aqueous layer was extracted with ethyl acetate (2 x 200 mL). The organic layers were combined, dried over sodium sulfate, filtered and concentrated in vacuo to afford the title compound as a light yellow oil (31 .5 g, 84percent). 1H NMR (400MHz, CDCl3): δ ppm 1.43 (m, 3H), 4.43 (m, 2H), 6.74 (m, 1 H), 7.79 (m, 1 H), 8.07 (m, 1 H). LCMS Rt = 2.45 minutes MS m/z 203 [MH]+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | Reflux | 3-Bromo-2-chloropyridine (10.0 g, 52.0 mmol) was dissolved in ethanol (100 mL) and a solution of sodium ethylate in ethanol (70.8 mL, 21 percent) was added. The mixture was heated to reflux overnight. The solvent was then removed in vacuo and the residue was dissolved in ethyl acetate and washed with satd. aqueous ammonium chloride solution. The organic layer was dried over sodium sulphate, and the solvent was evaporated. The crude product was purified by column chromatography on silica gel (eluent: cyclohexane / ethyl acetate 10: 1 ) to yield 7.26 g (69percent) of an yellow oil. 1H-NMR (400MHz, DMSO-d6): δ [ppm]= 1 .34 (t, 3H), 4.37 (q, 2H), 6.93 (dd, 1 H), 8.02 (dd, 1 H), 8.15 (dd, 1 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | Reflux | Intermediate [Example Int22.13-bromo-2-ethoxypyridine3-Bromo-2-chloropyridine (10.0 g) was dissolved in ethanol (100 mL) and a solution of sodium ethylate in ethanol (70.8 mL, 21 percent) was added. The mixture was heated to reflux overnight. The solvent was then removed in vacuo and the residue was dissolved in ethyl acetate and washed with satd. aqueous ammonium chloride solution. The organic layer was dried over sodium sulphate, and the solvent was evaporated. The crude product was purified by column chromatography on silica gel (eluent: cyclohexane / ethyl acetate 10: 1 ) to yield 7.26 g (69percent) of an yellow oil.1 H-NMR (400MHz, DMSO-d6): δ [ppm]= 1 .34 (t, 3H), 4.37 (q, 2H), 6.93 (dd, 1 H), 8.02 (dd, 1 H), 8.15 (dd, 1 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In dimethyl sulfoxide at 95℃; for 6 h; Inert atmosphere | A suspension of 3-bromo-2-ethoxypyridine (Preparation 1 1 , 28.69 g, 142.0 mmol), bis(pinacolato)diboron (43.3 g, 170.5 mmol), and potassium acetate (41 .8 g, 425.9 mmol) in DMSO (100 mL) was degassed with nitrogen and [1 ,1 '- bis(diphenylphosphinoferrocene]dichloro palladium (II) (5.8 g, 7.93 mmol) was added and the reaction mixture was stirred for 6 hours at 95 °C. The reaction mixture was filtered through a pad of Arbocel which was washed with ethyl acetate (500 mL). The filtrate was concentrated in vacuo and the crude material was purified by silica gel column chromatography eluting with 50percent ethyl acetate in cyclohexane to afford the title compound as a red oil (34.4g, 74percent). 1H NMR (400MHz, CDCl3): δ ppm 1 .35 (s, 12H), 1 .39 (m, 3H), 4.37 (m, 2H), 6.81 (m, 1 H), 7.89 (m, 1 H), 8.19 (m, 1 H). LCMS Rt = 3.27 minutes MS m/z 250 [MH]+ |
[ 717843-51-1 ]
3-Bromo-2-methoxy-4-methylpyridine
Similarity: 0.87
[ 760207-86-1 ]
3-Bromo-2-isopropoxy-5-methylpyridine
Similarity: 0.86
[ 717843-56-6 ]
3-Bromo-2-methoxy-5-methylpyridine
Similarity: 0.85
[ 717843-51-1 ]
3-Bromo-2-methoxy-4-methylpyridine
Similarity: 0.87
[ 760207-86-1 ]
3-Bromo-2-isopropoxy-5-methylpyridine
Similarity: 0.86
[ 717843-56-6 ]
3-Bromo-2-methoxy-5-methylpyridine
Similarity: 0.85
[ 717843-51-1 ]
3-Bromo-2-methoxy-4-methylpyridine
Similarity: 0.87
[ 760207-86-1 ]
3-Bromo-2-isopropoxy-5-methylpyridine
Similarity: 0.86
[ 717843-56-6 ]
3-Bromo-2-methoxy-5-methylpyridine
Similarity: 0.85